• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 疾病负担:加强国家研究合作。

Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies.

机构信息

National Food Institute, Technical University of Denmark, Kgs Lyngby, Denmark.

Place and Wellbeing Directorate, Public Health Scotland, Glasgow, United Kingdom.

出版信息

Front Public Health. 2022 Jun 3;10:907012. doi: 10.3389/fpubh.2022.907012. eCollection 2022.

DOI:10.3389/fpubh.2022.907012
PMID:35734754
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9208200/
Abstract

OBJECTIVES

Quantifying the combined impact of morbidity and mortality is a key enabler to assessing the impact of COVID-19 across countries and within countries relative to other diseases, regions, or demographics. Differences in methods, data sources, and definitions of mortality due to COVID-19 may hamper comparisons. We describe efforts to support countries in estimating the national-level burden of COVID-19 using disability-adjusted life years.

METHODS

The European Burden of Disease Network developed a consensus methodology, as well as a range of capacity-building activities to support burden of COVID-19 studies. These activities have supported 11 national studies so far, with study periods between January 2020 and December 2021.

RESULTS

National studies dealt with various data gaps and different assumptions were made to face knowledge gaps. Still, they delivered broadly comparable results that allow for interpretation of consistencies, as well as differences in the quantified direct health impact of the pandemic.

DISCUSSION

Harmonized efforts and methodologies have allowed for comparable estimates and communication of results. Future studies should evaluate the impact of interventions, and unravel the indirect health impact of the COVID-19 crisis.

摘要

目的

量化发病率和死亡率的综合影响是评估 COVID-19 在国家间和国家内相对于其他疾病、地区或人口的影响的关键手段。由于 COVID-19 导致的死亡率在方法、数据源和定义方面的差异可能会阻碍比较。我们描述了使用伤残调整生命年来支持各国估算 COVID-19 国家层面负担的努力。

方法

欧洲疾病负担网络制定了一项共识方法以及一系列能力建设活动,以支持 COVID-19 研究的负担。这些活动迄今为止已支持了 11 项国家研究,研究期间为 2020 年 1 月至 2021 年 12 月。

结果

国家研究解决了各种数据差距,并针对知识差距做出了不同的假设。尽管如此,它们提供了广泛可比的结果,允许解释一致性,以及大流行对直接健康影响的量化差异。

讨论

协调一致的努力和方法允许进行可比的估算和结果交流。未来的研究应评估干预措施的影响,并揭示 COVID-19 危机的间接健康影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca8/9208200/f8e074a13409/fpubh-10-907012-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca8/9208200/f8e074a13409/fpubh-10-907012-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ca8/9208200/f8e074a13409/fpubh-10-907012-g0001.jpg

相似文献

1
Burden of Disease of COVID-19: Strengthening the Collaboration for National Studies.COVID-19 疾病负担:加强国家研究合作。
Front Public Health. 2022 Jun 3;10:907012. doi: 10.3389/fpubh.2022.907012. eCollection 2022.
2
The Burden of Disease due to COVID-19 (BoCO-19): A study protocol for a secondary analysis of surveillance data in Southern and Eastern Europe, and Central Asia.《COVID-19 疾病负担(BoCO-19)研究:一项对南欧、东欧和中亚地区监测数据进行二次分析的研究方案》。
PLoS One. 2023 Oct 13;18(10):e0292041. doi: 10.1371/journal.pone.0292041. eCollection 2023.
3
Disability adjusted life years associated with COVID-19 in Denmark in the first year of the pandemic.大流行第一年丹麦与 COVID-19 相关的残疾调整生命年。
BMC Public Health. 2022 Jul 9;22(1):1315. doi: 10.1186/s12889-022-13694-9.
4
Modelling the potential acute and post-acute burden of COVID-19 under the Australian border re-opening plan.模拟澳大利亚边境重新开放计划下 COVID-19 的潜在急性和后期负担。
BMC Public Health. 2022 Apr 14;22(1):757. doi: 10.1186/s12889-022-13169-x.
5
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.2020 年印度因 COVID-19 直接健康影响导致的伤残调整生命年(DALYs)。
Sci Rep. 2022 Feb 14;12(1):2454. doi: 10.1038/s41598-022-06505-z.
6
Estimating the Direct Disability-Adjusted Life Years Associated With SARS-CoV-2 (COVID-19) in the Republic of Ireland: The First Full Year.估算与 SARS-CoV-2(COVID-19)相关的直接伤残调整生命年在爱尔兰共和国的情况:第一年。
Int J Public Health. 2022 Jun 2;67:1604699. doi: 10.3389/ijph.2022.1604699. eCollection 2022.
7
Burden of COVID-19: DALY and productivity loss for Karnataka, India.COVID-19 负担:印度卡纳塔克邦的 DALY 和生产力损失。
Indian J Public Health. 2022 Jul-Sep;66(3):239-244. doi: 10.4103/ijph.ijph_959_21.
8
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
The need for holistic, longitudinal and comparable, real-time assessment of the emotional, behavioral and societal impact of the COVID-19 pandemic across nations.需要对新冠疫情在各国造成的情感、行为和社会影响进行全面、纵向、可比的实时评估。
Psychiatriki. 2021 Apr 19;32(1):15-18. doi: 10.22365/jpsych.2021.010. Epub 2021 Mar 8.
10
Burden of COVID-19: Disability-Adjusted Life Years (DALYs) across 16 European countries.新冠疫情负担:16个欧洲国家的伤残调整生命年(DALYs)
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5529-5541. doi: 10.26355/eurrev_202109_26665.

引用本文的文献

1
Calculation of COVID-19 disease burden using Monte Carlo simulation with dynamic disability weights and analysis of transmission characteristics.使用动态残疾权重的蒙特卡罗模拟计算COVID-19疾病负担并分析传播特征。
BMC Public Health. 2025 Jun 2;25(1):2041. doi: 10.1186/s12889-025-23273-3.
2
Smart oxygen monitoring in hospitals: a pilot study during COVID-19.医院中的智能氧气监测:COVID-19 期间的一项试点研究。
Sci Rep. 2025 Jan 25;15(1):3160. doi: 10.1038/s41598-025-87665-6.
3
Epidemic Intelligence Threat Reporting Profile in Portugal during the COVID-19: 2 Years of Decrease in Reporting on Non-COVID-19 Threats.

本文引用的文献

1
Measuring disability-adjusted life years (DALYs) due to COVID-19 in Scotland, 2020.2020年苏格兰因新型冠状病毒肺炎所致伤残调整生命年的测算
Arch Public Health. 2022 Apr 1;80(1):105. doi: 10.1186/s13690-022-00862-x.
2
Disability-adjusted life years (DALYs) due to the direct health impact of COVID-19 in India, 2020.2020 年印度因 COVID-19 直接健康影响导致的伤残调整生命年(DALYs)。
Sci Rep. 2022 Feb 14;12(1):2454. doi: 10.1038/s41598-022-06505-z.
3
Burden of severe COVID-19 in center of Iran: results of disability-adjusted life years (DALYs).
COVID-19 期间葡萄牙的疫情情报威胁报告概况:非 COVID-19 威胁报告减少的两年
Port J Public Health. 2024 Jul 11;42(2):121-132. doi: 10.1159/000539616. eCollection 2024 Aug.
4
Economic Evaluation of COVID-19 Screening Tests and Surveillance Strategies in Low-Income, Middle-Income, and High-Income Countries: A Systematic Review.经济评估 COVID-19 筛查试验和监测策略在低收入、中等收入和高收入国家:系统评价。
Med Sci Monit. 2024 Apr 21;30:e943863. doi: 10.12659/MSM.943863.
5
Building a precision medicine infrastructure at a national level: The Swedish experience.在国家层面构建精准医疗基础设施:瑞典的经验。
Camb Prism Precis Med. 2023 Feb 27;1:e15. doi: 10.1017/pcm.2023.3. eCollection 2023.
6
A Study on Community needs, perceptions and demand regarding the use of the health services during COVID-19 pandemic in district Kathua, J and K.关于查谟和克什米尔邦卡图阿地区在新冠疫情期间社区对医疗服务使用的需求、认知及要求的研究
J Family Med Prim Care. 2023 Dec;12(12):3092-3097. doi: 10.4103/jfmpc.jfmpc_2145_22. Epub 2023 Dec 21.
7
Estimating the disability adjusted life years associated with COVID-19 in Iran for the first 2 years of the pandemic.估算伊朗在新冠疫情大流行的头两年中与新冠病毒病相关的伤残调整生命年。
Front Public Health. 2024 Jan 11;11:1303549. doi: 10.3389/fpubh.2023.1303549. eCollection 2023.
8
Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers.在日本和白种健康志愿者中静脉或肌内注射抗 SARS-CoV-2 单克隆抗体 sotrovimab 的药代动力学、安全性和耐受性。
Clin Pharmacokinet. 2024 Jan;63(1):57-68. doi: 10.1007/s40262-023-01319-2. Epub 2023 Nov 13.
9
A proposal for further developing fatigue-related post COVID-19 health states for burden of disease studies.一项关于进一步开发与疲劳相关的新冠后健康状态以用于疾病负担研究的提议。
Arch Public Health. 2023 Nov 2;81(1):193. doi: 10.1186/s13690-023-01212-1.
10
The Burden of Disease due to COVID-19 (BoCO-19): A study protocol for a secondary analysis of surveillance data in Southern and Eastern Europe, and Central Asia.《COVID-19 疾病负担(BoCO-19)研究:一项对南欧、东欧和中亚地区监测数据进行二次分析的研究方案》。
PLoS One. 2023 Oct 13;18(10):e0292041. doi: 10.1371/journal.pone.0292041. eCollection 2023.
伊朗中部重症新冠病毒疾病负担:伤残调整生命年(DALYs)结果
Int J Mol Epidemiol Genet. 2021 Dec 15;12(6):120-125. eCollection 2021.
4
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021.根据 2020 年 12 月至 2021 年 11 月期间在世界卫生组织欧洲区域内,60 岁及以上人群因接种 COVID-19 疫苗而直接避免的死亡人数估计数。
Euro Surveill. 2021 Nov;26(47). doi: 10.2807/1560-7917.ES.2021.26.47.2101021.
5
Unravelling data for rapid evidence-based response to COVID-19: a summary of the unCoVer protocol.揭开数据的面纱,为 COVID-19 提供快速基于证据的应对措施:unCoVer 方案概述。
BMJ Open. 2021 Nov 18;11(11):e055630. doi: 10.1136/bmjopen-2021-055630.
6
Burden of Disease Methods: A Guide to Calculate COVID-19 Disability-Adjusted Life Years.疾病负担方法:计算新冠病毒病伤残调整生命年指南
Int J Public Health. 2021 Mar 5;66:619011. doi: 10.3389/ijph.2021.619011. eCollection 2021.
7
Estimating the direct Covid-19 disability-adjusted life years impact on the Malta population for the first full year.估算新冠疫情第一年对马耳他人口造成的直接伤残调整生命年影响。
BMC Public Health. 2021 Oct 9;21(1):1827. doi: 10.1186/s12889-021-11893-4.
8
Inequalities in population health loss by multiple deprivation: COVID-19 and pre-pandemic all-cause disability-adjusted life years (DALYs) in Scotland.多重剥夺导致的人口健康损失不平等:苏格兰的 COVID-19 和大流行前全因残疾调整生命年(DALYs)。
Int J Equity Health. 2021 Sep 26;20(1):214. doi: 10.1186/s12939-021-01547-7.
9
Disability-Adjusted Life Years for the COVID-19 Pandemic in the Mexican Population.墨西哥人口中与 COVID-19 大流行相关的残疾调整生命年。
Front Public Health. 2021 Aug 17;9:686700. doi: 10.3389/fpubh.2021.686700. eCollection 2021.
10
Recommendations to plan a national burden of disease study.关于规划全国疾病负担研究的建议。
Arch Public Health. 2021 Jul 7;79(1):126. doi: 10.1186/s13690-021-00652-x.